Relationship between resistin and aPAI-1 levels with insulin resistance in Saudi children

Pediatrics International

Volumn 52, Issue 4, 2010, Pages 551-556

  Al Daghri, Nasser M ^a   Al Attas, Omar S ^a   Alokail, Majed S ^a   Alkharfy, Khalid M ^b   Draz, Hossam M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

childhood obesity; insulin resistance; plasminogen activator inhibitor 1; resistin

Indexed keywords

ANGIOTENSIN II; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRIACYLGLYCEROL;

ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAUDI ARABIA; SCHOOL CHILD; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN;

EID: 77955790232     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03091.x     Document Type: Article

References (42)

1. Dietz WH. Overweight in childhood and adolescence. N. Engl. J. Med. 2004 350 : 855 7.
2. Deitel M. The International Obesity Task Force and "globesity". Obes. Surg. 2002 12 : 613 14.
3. Must A. Does overweight in childhood have an impact on adult health? Nutr. Rev. 2003 61 : 139 42.
4. Magarey AM, Daniels LA, Boulton TJ, Cockington RA. Predicting obesity in early adulthood from childhood and parental obesity. Int. J. Obes. Relat. Metab. Disord. 2003 27 : 505 13.
5. St-Onge MP, Heymsfield SB. Overweight and obesity status are linked to lower life expectancy. Nutr. Rev. 2003 61 : 313 16.
6. AlNuaim AR, Bamgboye EA, AlHerbish A. The pattern of growth and obesity in Saudi Arabian male school children. Int. J. Obes. 1996 20 : 1000 5.
7. El-Hazmi MA, Warsy AS. A comparative study of prevalence of overweight and obesity in children in different provinces of Saudi Arabia. J. Trop. Pediatr. 2002 48 : 172 7.
8. Holcomb IN, Kabakoff RC, Chan B et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 2000 19 : 4046 55.
9. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001 409 : 307 12.
10. Palanivel R, Sweeney G. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett. 2005 22 : 5049 54.
11. Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes. 2004 53 : 1279 84.
12. Azuma K, Katsukawa F, Oguchi S et al. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 2003 11 : 997 1001.
13. Lee JH, Chan JL, Yiannakouris N et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 2003 88 : 4848 56.
14. Youn BS, Yu KY, Park HJ et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2004 89 : 150 56.
15. Heilbronn LK, Rood J, Janderova L et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 2004 89 : 1844 8.
16. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 1991 88 : 1067 72.
17. Tsikouris JP, Suarez JA, Meyerrose GE. Plasminogen activator inhibitor-1: Physiologic role, regulation, and the influence of common pharmacologic agents. J. Clin. Pharmacol. 2002 42 : 1187 99.
18. Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann. Med. 2000 32 (Suppl. 1 78 84.
19. Hoffstedt J, Andersson IL, Persson L, Isaksson B, Arner P. The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity. Diabetologia 2002 45 : 584 7.
20. Kinik ST, Ozbek N, Yuce M, Yazici AC, Verdi H, Ata FB. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children. Thromb. Haemost. 2008 99 : 352 6.
21. Zanchetti A, Ruilope LM. Antihypertensive treatment in patients with type-2 diabetes mellitus: What guidance from recent controlled randomized trials? J. Hypertens. 2002 20 : 2099 110.
22. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J. Hypertens. 2005 23 : 463 73.
23. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997 138 : 1512 19.
24. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiation of preadipose cells: Paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 1994 135 : 2030 36.
25. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R. Angiotensin II as a trophic factor of white adipose tissue: Stimulation of adipose cell formation. Endocrinology 2001 142 : 487 92.
26. Olivares-Reyes JA, Arellano-Plancarte A, Castillo-Hernandez JR. Angiotensin II and the development of insulin resistance: Implications for diabetes. Mol. Cell. Endocrinol. 2009 302 : 128 39.
27. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000 320 : 1240 46.
28. Umeda M, Ichikawa SC, Kanda T, Sumino H, Kobayashi I. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am. J. Hypertens. 2001 14 : 206 11.
29. Gerber M, Boettner A, Seidel B et al. Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab. 2005 90 : 4503 9.
30. Li M, Fisette A, Zhao X-Y, Deng J-Y, Mi J, Cianflone K. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int. J. Obes. 2009 33 : 424 39.
31. Reinehr T, Roth CL, Menke T, Andler W. Resistin concentrations before and after weight loss in obese children. Int. J. Obes. 2006 30 : 297 301. (Pubitemid 43237686)
32. Silha JV, Kresk M, Skrha JV, Sucharada P, Nyomba BLG, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur. J. Endocrinol. 2003 149 : 331 5.
33. Nogueiras R, Gualillo O, Caminos E, Casanueva FF, Die'guez C. Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes. Res. 2003 11 : 408 14.
34. Fujinami A, Obayashi H, Ohata K et al. Enzyme-linked immunosorbent assay for circulating human resistin: Resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta 2004 339 : 57 63.
35. Zou CC, Liang L, Hong F. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Ind. Pediatr. 2007 44 : 275 9.
36. Kim S, Soltani-Bejnood M, Quignard-Boulange A et al. The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J. Biomed. Biotechnol. 2006 5 : 27 012.
37. Estellés A, Dalmau J, Falcó C et al. Plasma PAI-1 levels in obese children: Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Thromb. Haemost. 2001 86 : 647 52.
38. Shiga K, Kikuchi N. Children with type 2 diabetes mellitus are at greater risk of macrovascular complications. Pediatr. Int. 2009 51 : 563 7.
39. Cao YL, Wang YX, Wang DF, Meng X, Zhang J. Correlation between omental TNF-alpha protein and plasma PAI-1 in obesity subjects. Int. J. Cardiol. 2008 128 : 399 405.
40. De Pergola G, Pannacciulli N, Coviello M et al. sP-selectin plasma levels in obesity: Association with insulin resistance and related metabolic and prothrombotic factors. Nutr. Metab. Cardiovasc. Dis. 2008 18 : 227 32.
41. Asplund-Carlson A, Hamsten A, Wiman B, Carlson LA. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: Studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia 1993 36 : 817 25.
42. Giltay EJ, Elbers JM, Gooren LJ et al. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: Modulation by cross-sex hormone administration. Arterioscler. Thromb. Vasc. Biol. 1998 18 : 1716 22.